Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.52 USD | +2.33% | +19.66% | +146.85% |
Apr. 23 | Chromadex Announces Inaugural Major Grocery Debut of Tru Niagen® At Sprouts Farmers Market | CI |
Apr. 09 | Roth MKM Raises Price Target on ChromaDex to $6 From $4.25, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+146.85% | 260M | |
+1.46% | 42.75B | |
+47.70% | 41.61B | |
+12.06% | 41.34B | |
-8.83% | 26.59B | |
+7.12% | 25.49B | |
-23.25% | 18.12B | |
+30.23% | 12.24B | |
-2.43% | 11.76B | |
+8.44% | 11B |
- Stock Market
- Equities
- CDXC Stock
- News ChromaDex Corporation
- ChromaDex Says High-Dose Niagen Safe for Parkinson's Disease Patients in Phase 1 Study